Labelling of EDTMP (Multibone®) with [111In], [ 99mTc] and [188Re] using different carriers for "cross complexation"

Applied Radiation and Isotopes

Volumn 60, Issue 5, 2004, Pages 653-658

  Mitterhauser, Markus ^a,b,c   Wadsak, Wolfgang ^b,c,d   Eidherr, Harald ^b,c   Krcal, Andreas ^b   Kletter, Kurt ^b   Dudczak, Robert ^b,d   Viernstein, Helmut ^c   Pirich, Christian ^b  

^a Anstaltsapotheke Allgemeinen K   (Austria)

^b MEDICAL UNIVERSITY OF VIENNA   (Austria)

^c UNIVERSITY OF VIENNA   (Austria)

^d LUDWIG BOLTZMANN INSTITUTE FOR LUNG VASCULAR RESEARCH   (Austria)

Author keywords

Bone uptake; Cross complexation; EDTMP; Phosphonates

Indexed keywords

BONE; INDIUM COMPOUNDS; RADIOISOTOPES; RHODIUM COMPOUNDS;

METASTASES; RADIOTRACERS;

NUCLEAR MEDICINE;

ETHYLENE DIAMINO N,N,N',N' TETRAKISMETHYLENE PHOSPHORIC ACID IN 111; ETHYLENE DIAMINO N,N,N',N' TETRAKISMETHYLENE PHOSPHORIC ACID RE 188; ETHYLENE DIAMINO N,N,N',N' TETRAKISMETHYLENE PHOSPHORIC ACID TC 99M; INDIUM 111; PHOSPHORIC ACID; RHENIUM 188; TECHNETIUM 99M; UNCLASSIFIED DRUG;

ARTICLE; CHEMICAL MODIFICATION; COMPLEX FORMATION; DRUG UPTAKE; ISOTOPE LABELING; PRIORITY JOURNAL;

INDIUM RADIOISOTOPES; ISOTOPE LABELING; KINETICS; LIGANDS; ORGANOMETALLIC COMPOUNDS; ORGANOPHOSPHORUS COMPOUNDS; ORGANOTECHNETIUM COMPOUNDS; RADIOISOTOPES; RHENIUM; TECHNETIUM;

EID: 1842788825     PISSN: 09698043     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.apradiso.2003.09.014     Document Type: Article

References (21)

1. 177Lu EDTMP. a potential therapeutic bone agent Nucl. Med. Comm. 19:1998;587-591.
2. 105Rh-EDTMP and its bone accumulation. Appl. Radiate Isot. 52:2000;211-215.
3. Beyer G.J., Offord R., Künzi G., Aleksandrova Y., Ravn U., Jahn S., Barker J., Tengblad O., Lindroos M. The influence of EDTMP-concentration on the biodistribution of radio-lanthanides and 225Ac in tumor-bearing mice. Nucl. Med. Biol. 24:1997;367-372.
4. 186ReHEDP. Inorg. Chem. 36:1997;3055-3063.
5. Francis M.D., Ferguson D.L., Tofe A.J., Bevan J.A., Michaels S.E. Comparative evaluation of three diphosphonates. in vitro adsorption (C-14 labeled) and in vivo osteogenic uptake (Tc-99m complexed) J. Nucl. Med. 21:1980;1185-1189.
6. 188Re, and a study of their stability. Appl. Radiate Isot. 51:1999;307-313.
7. 99mTc-EDTMP. J. Nucl. Med. 17:1976;508-511.
8. 113mIn-labeled Bone scanning agents. Radiology. 117:1975;727-730.
9. Kanishi D. 99mTc-MDP accumulation mechanisms in bone. Oral Sur. Oral Med. Oral Pathol. 75:1993;239-246.
10. Ketring A.R. 153Sm-EDTMP and 186Re-HEDP as bone therapeutic radiopharmaceuticals. Int. J. Rad. Appl. Instr. Part B, Nucl. Med. Biol. 14:1987;223-232.
11. Láznícek M., Láznícková A., Budský F., Prokop J., Kopicka K. Comparison of biological characteristics of EDTMP complexes with 99mTc, 111In and 153Sm in rats. Appl. Radiate Isot. 45:1994;949-953.
12. Liepe K., Franke W.G., Kropp J., Koch R., Runge R., Hliscs R. Comparison of rhenium-188, rhenium-186-HEDP and strontium-89 in palliation of painful bone metastases. Nucl. Med. 39:2000;146-151.
13. Louw, W.K., Dormehl, I.C., van Rensburg, A.J., Hugo, N., Alberts, A.S., Forsyth, O.E., Beverley, G., Sweetlove, M.A., Marais, J., Lötter, M.G., van Aswegen, A., 1996. Evaluation of Samarium-153 and Holmium-166-EDTMP in the Normal Baboon Model. Nucl. Med. Biol. 23, 935-940.
14. Mitterhauser M., Krcal A., Dudczak R., Traub T., Oflouglu S., Viernstein H., Pirich C. Synthesis of 99mTc EDTMP using perrhenic acid as carrier - radiopharmaceutical and clinical results. Eur. J. Nucl. Med. 28:2001;1028.
15. Nicolay O.F., Heeley J.D., Jeffcoat M.K., Jones A.G. Autoradiographic localization of technetium-99m methylene diphosphonate in growth sites of young mice. Int. J. Radiate Appl. Instr. Part B Nucl. Med. Biol. 15:1988;157-163.
16. Noronha O.P., Venkateswarlu K.S. On the nature of technetium compounds. A semiquantitative biological model system to assay 99mTc-complexes/ radiopharmaceuticals. Eur. J. Nucl. Med. 6:1981;121-129.
17. Oh S.J., Won K.S., Moon D.H., Cheon J.H., Ha H.J., Jeong J.M., Lee H.K. Preparation and biological evaluation of 188Re-ethylenediamine-N,N,N′, N′-tetrakis-(methylene phosphonic acid) as a potential agent for bone pain palliation. Nucl. Med. Comm. 23:2002;75-81.
18. Okamoto Y. Accumulation of technetium-99m methylene diphosphonate. Conditions affecting adsorption to hydroxyapatite. Oral Surg. Oral Med. Oral Pathol. Oral Radiol. Endodont. 80:1995;115-119.
19. Palmedo H., Guhlke S., Bender F., Sartor J., Schoeneich G., Risse J., Grünwald F., Knapp F.F., Biersack H.J. Dose escalation study with rhenium-188 hydroxyethylidede diphosphonate in prostate cancer patients with osseous metastases. Eur. J. Nucl. Med. 27:2000;123-130.
20. Rösch F., Herzog H., Plag C., Neumaier B., Braun U., Müller-Gärtner H.W., Stöcklin G. Radiation doses of yttrium-90 citrate and yttrium-90 EDTMP as determined via analogous yttrium-86 complexes and positron emission tomography. Eur. J. Nucl. Med. 23:1996;958-966.
21. Subramanian G., McAfee J.G., Rosenstreich M., Coco M. Indium-113m-labeled polyfunctional phosphonates as bone-imaging agents. J. Nucl. Med. 16:1975;1080-1084.